BCX10013
BCX10013-105
Phase 1 small_molecule completed
Quick answer
BCX10013 for Paroxysmal Nocturnal Hemoglobinuria is a Phase 1 program (small_molecule) at BIOCRYST PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BIOCRYST PHARMACEUTICALS INC
- Indication
- Paroxysmal Nocturnal Hemoglobinuria
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed